Artículo
Evaluation of cytokines as adjuvants of infectious bovine keratoconjunctivitis vaccines
Di Girolamo, Fabio Augusto
; Sabatini, Diego Jorge; Fasan, Raúl A.; Echegoyen, Maia; Vela, Mauro; Pereira, Claudio Alejandro
; Maure, Pablo
Fecha de publicación:
01/2012
Editorial:
Elsevier Science
Revista:
Veterinary Immunology And Immunopathology
ISSN:
0165-2427
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
In this work two cytokines were used in combination with inactivated bacteria (bacterin) to test the bovine conjuctival immune response to the pathogen Moraxella bovis, the causative agent of Infectious bovine keratoconjunctivitis (IBK). Treatments using the bacterin vaccine combined with interleukin-2 and interferon-α as adjuvants (Group A), the bacterin vaccine only (Group B), and controls without treatment (Group C), were applied by ocular spraying to evaluate the local immune response in the corneal structure of cattle experimentally infected with M. bovis. Six weeks after infection, 14 out of a total of 34 animals presented different corneal lesions; 9 corresponding to the control group C, 4 to the group B and only one to the group A. According to the clinical manifestations, a numeric score was calculated. Control animals presented the highest score value (12 points), followed by group B (7.5 points) and group A (1 point). These results suggest that the addition of cytokines to M. bovis treatments can reduce not only eye injuries caused by IBK but also the number of diseased animals. © 2012 Elsevier B.V.
Palabras clave:
Cytokines
,
Infectious Bovine Keratoconjunctivitis
,
Moraxella Bovis
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(IDIM)
Articulos de INST.DE INVEST.MEDICAS
Articulos de INST.DE INVEST.MEDICAS
Citación
Di Girolamo, Fabio Augusto; Sabatini, Diego Jorge; Fasan, Raúl A.; Echegoyen, Maia; Vela, Mauro; et al.; Evaluation of cytokines as adjuvants of infectious bovine keratoconjunctivitis vaccines; Elsevier Science; Veterinary Immunology And Immunopathology; 145; 1-2; 1-2012; 563-566
Compartir
Altmétricas